OBJECTIVES: Effective hypertension control remains low without much improvement since the 1990s. However, information is limited whether and how social status impacts on hypertension control. METHODS: Data from the German Health Survey 1998 are used to explore the role of social status according to educational achievement in treating hypertension, adjusted for key determinants in a logistic regression. RESULTS: Actual as well as population prevalence (≥140 mmHg/≥90 mmHg) is highest in the lowest of the three social classes with 59.4 and 51.9% as compared to 44.5 and 40.5% in the highest. Physician contacts during the previous year were also highest in the lower class with 76.0% as compared to 59.0% in the highest. The logistic regression revealed insignificant odds ratios (OR) of 1.46 for the highest and 1.12 for the middle class for treatment of known hypertension after adjusting for gender (OR for females, 1.38), age (OR for 60-69 years, 13.13), GP visits (OR, 1.43) and living in East Germany (OR, 1.56). CONCLUSIONS: German survey data for antihypertensive treatment do not show any significant disadvantage for the lowest social class.
OBJECTIVES: Effective hypertension control remains low without much improvement since the 1990s. However, information is limited whether and how social status impacts on hypertension control. METHODS: Data from the German Health Survey 1998 are used to explore the role of social status according to educational achievement in treating hypertension, adjusted for key determinants in a logistic regression. RESULTS: Actual as well as population prevalence (≥140 mmHg/≥90 mmHg) is highest in the lowest of the three social classes with 59.4 and 51.9% as compared to 44.5 and 40.5% in the highest. Physician contacts during the previous year were also highest in the lower class with 76.0% as compared to 59.0% in the highest. The logistic regression revealed insignificant odds ratios (OR) of 1.46 for the highest and 1.12 for the middle class for treatment of known hypertension after adjusting for gender (OR for females, 1.38), age (OR for 60-69 years, 13.13), GP visits (OR, 1.43) and living in East Germany (OR, 1.56). CONCLUSIONS: German survey data for antihypertensive treatment do not show any significant disadvantage for the lowest social class.
Authors: Katharina Wolf-Maier; Richard S Cooper; José R Banegas; Simona Giampaoli; Hans-Werner Hense; Michel Joffres; Mika Kastarinen; Neil Poulter; Paola Primatesta; Fernando Rodríguez-Artalejo; Birgitta Stegmayr; Michael Thamm; Jaakko Tuomilehto; Diego Vanuzzo; Fenicia Vescio Journal: JAMA Date: 2003-05-14 Impact factor: 56.272
Authors: Paul Muntner; Dongfeng Gu; Xiqui Wu; Xiufang Duan; Gan Wenqi; Paul K Whelton; Jiang He Journal: Hypertension Date: 2004-01-26 Impact factor: 10.190